The present invention provides compounds of Formula I:
1
wherein the variables A, B, Ar, R
1
, R
2
, and R
3
are as defined herein. The compounds of Formula (I) can function as corticotropin releasing factor (CRF) receptor antagonists and can be useful, for example, in the treatment of disorders characterized by abnormal levels of CRF such as anxiety and depression.
本发明提供了I式化合物:1其中变量A、B、Ar、R1、R2和R3的定义如本文所述。I式化合物可以作为促
肾上腺皮质激素释放因子(CRF)受体拮抗剂,并可用于治疗CRF
水平异常的疾病,如焦虑和抑郁症等。